跳至主要内容
临床试验/IRCT20180421039369N2
IRCT20180421039369N2招募中未知

The study of the efficacy of the Transdiagnostic Treatment of the Unified for the Improvement of Comorbid Psychological Disorders (Depression, Anxiety and Health Anxiety), Fatigue and Quality of Life in Patients with Multiple Sclerosis (Ms)

Kermanshah University of Medical Sciences0 个研究点目标入组 45 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 50 years(—)
性别
All

入选标准

  • Suffering Ms disease with diagnosis of the neurological department
  • Having a score of less than 5 in the (EDSS) Disability Indicator based on a neurologist's assessment to determine the individual's ability to attend a therapeutic session
  • The age range is between 50 to 18 years old
  • Affliction of emotional coexistence disorders including depression, anxiety and health anxiety based on diagnostic interview by psychologist
  • Motivation and satisfaction for participation during treatment and research implementation
  • Failure to receive psychological treatment in the past year
  • Have at least a cycle of educationNot having other chronic diseases such as severe liver disorder
  • The lack of current diagnosis of any mental disorder is consistent in Diagram 1 and 2 based on a psychologist's diagnostic interview, with the exception of emotional disorders including depression, anxiety and health anxiety
  • No obvious risk of suicide now
  • There is no history of drug abuse or dependence at the current time and within one year before the start of treatment

排除标准

  • Unwillingness to attend research meetings
  • Not attending at least 50% of the sessions
  • Creating severe physical problems so that it can not be present at meetings

研究者

相似试验

The study of the efficacy of the Transdiagnostic... | 临床试验